Bladder cancer Board decisions

The Board granted an effective date of August 26, 2014, for the award of service connection for residuals of bladder cancer due to continuous pursuit of the claim.

The Board granted an effective date of June 29, 2021, for the award of service connection for residuals of bladder cancer and associated disabilities.

The Board remands the claims for service connection for diabetes mellitus type II and bladder cancer due to insufficient evidence regarding potential toxic exposure risk activities, including burn pits.

The Veteran withdrew his appeal for service connection of bladder cancer, and the Board has no jurisdiction to review this issue.

The Board denied the veteran's claim for service connection for bladder cancer, finding that there is no credible evidence of in-service exposure to herbicides or other relevant factors.

The Board remands the claims for further development, including obtaining a VA examination and opinion to determine the nature and etiology of the Veteran's obstructive sleep apnea and urinary bladder cancer, as well as scheduling the Veteran for VA examinations to assess the current severity of his service-connected disabilities.

The Board granted service connection for diabetes mellitus, type II, with diabetic nephropathy and diabetic retinopathy, coronary artery disease with cardiac stent status-post acute myocardial infarction, and hypertension under the PACT Act, effective February 13, 2023.

The Board denied service connection for bronchitis and liver condition, granted a 10 percent rating for costochondritis, and remanded several other claims for further development.

The appeal of a proposed reduction of the Veteran's service-connected bladder cancer from 100 percent to 20 percent was dismissed due to it being premature.

The Board denied the claim for service connection for the cause of the Veteran's death, finding that there was no evidence linking his medical conditions to his active service.

The Board remands the claim for a bladder disability, to include bladder cancer, as it requires an adequate medical opinion that considers all relevant evidence and accurately addresses the Veteran's in-service medical history.

The Board remands the claims for service connection for kidney cancer, diabetes mellitus, bladder cancer, and prostate cancer to ensure VA satisfies its duty to assist by providing a medical examination.

The Veteran's service connection for bladder cancer was granted due to presumptive exposure to herbicide agents during his service in Vietnam.

The Board remands the claim for service connection for bladder cancer to ensure an SSOC is issued addressing the Veteran's exposure at Camp Lejeune.

The Board granted service connection for the Veteran's bladder cancer, finding that it was due to exposure to fuels, oils, and gases during his military service.

The Board of Veterans' Appeals granted service connection for the Veteran's bladder cancer, finding that it was caused by his active-duty military service.

The Board denied an initial compensable evaluation for bladder cancer and dismissed the appeal for service connection for bilateral hearing loss due to untimely filing.

The Board granted service connection for bladder cancer, finding that the evidence is at least in approximate balance as to whether the Veteran's bladder cancer is etiologically related to his service.

The Board granted service connection for bladder cancer, finding that the Veteran's exposure to jet fuel during service was related to his condition.

The Board granted an effective date of October 2, 2018, for the grant of service connection for status post nephroureterectomy due to bladder cancer based on the Veteran's continuous pursuit of the claim and evidence linking the condition to in-service exposure.